Ownership history in BB BIOTECH AG · 14 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Sage Therapeutics, Inc. (SAGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | UNCHANGED | 1,375,229 | — | 0% | 5.50% | $218.7M | — |
| 2018 Q4 | ADDED | 1,375,229 | +303,856 | +28.4% | 4.22% | $131.7M | — |
| 2018 Q3 | UNCHANGED | 1,071,373 | — | 0% | 4.00% | $151.3M | — |
| 2018 Q2 | ADDED | 1,071,373 | +68,934 | +6.9% | 4.84% | $167.7M | — |
| 2018 Q1 | REDUCED | 1,002,439 | -40,000 | -3.8% | 4.46% | $161.5M | — |
| 2017 Q4 | REDUCED | 1,042,439 | -50,000 | -4.6% | 4.84% | $171.7M | — |
| 2017 Q3 | ADDED | 1,092,439 | +185,000 | +20.4% | 1.88% | $68.1M | — |
| 2017 Q2 | REDUCED | 907,439 | -65,000 | -6.7% | 2.21% | $72.3M | — |
| 2017 Q1 | REDUCED | 972,439 | -50,000 | -4.9% | 2.26% | $69.1M | — |
| 2016 Q4 | UNCHANGED | 1,022,439 | — | 0% | 1.93% | $52.2M | — |